An immunoblot diagnostic test for detecting IgG and IgA antibodies against Bordetella pertussis. This test is part of the ViraChip product line for infectious disease diagnostics.
Manufactured by
Viramed Biotech AG
Planegg, Germany
Based on 40 years of experience in European and American markets Viramed® develops, produces and sells In-Vitro-Diagnostic test kits. Through research and development, the ViraChip® microarray product group is continuously expanding. Viramed® focuses on the serological detection of autoantibodies and antibodies against infectious disease parameters like Borrelia, Yersinia, Treponema+VDRL, Helicobacter, Bordetella, SARS-CoV-2, EBV, CMV, Hepatitis E Virus, Parvovirus B19, Zika Virus, Dengue Virus and Chikungunya Virus and Toxoplasma. Software solutions, device design and manufacturing provide full automation for the ViraChip® technology in the diagnostic laboratory.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Gold Standard Diagnostics Frankfurt GmbH
Germany · 1 relevant product
PROTIA Inc.
South Korea · 1 relevant product
Vircell S.L.
Spain · 8 relevant products
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 89 closest product alternatives
Gold Standard Diagnostics Frankfurt GmbH · Germany
Serological test for detection of Bordetella pertussis-specific IgA antibodies and CatACT markers. Used for diagnosis and confirmation of pertussis infection in clinical laboratory settings. Enables rapid identification of acute or recent infection to guide appropriate patient management and infection control measures.
PROTIA Inc. · South Korea
PROTIA ImmuneCheck POCT is a point-of-care immunodiagnostic test for rapid detection of IgE, IgG, and IgA antibodies. Designed for clinical allergy assessment, autoimmune screening, and antibiotic susceptibility testing. Enables immediate results at the point of care for efficient patient management.
Vircell S.L. · Spain
A fully automated indirect chemiluminescent immunoassay (CLIA) in monotest format for the detection of Bordetella pertussis toxin IgG antibodies. The test is self-contained with all necessary reagents, calibrators, and controls included in the strip.
86 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products